AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vianglip SM 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Vivichem Pharma

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Vianglip SM 50mg/500mg Tablet

This dual-action 50mg/500mg tablet effectively manages elevated blood glucose in patients with type 2 diabetes, mitigating the risk of severe complications like vision impairment and kidney disease. It may also lessen the probability of cardiovascular events. This medication might be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual health status, glucose levels, and concurrent medications. Ingesting it with food minimizes gastrointestinal discomfort. Consistent daily use, at the same time, maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle significantly impacts blood sugar control. Common adverse effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia, a potential side effect, especially when combined with insulin or sulfonylureas, necessitates awareness of its symptoms and management. Prior to initiating treatment, individuals with pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption, should inform their physician. Consult your doctor before use during pregnancy or breastfeeding. Inform your physician of all other medications to ensure safe interaction, and alcohol intake should be minimized due to its potential to reduce blood glucose. Kidney function and blood sugar levels are regularly monitored throughout treatment.

Primary Ingredients of Vianglip SM 50mg/500mg Tablet

There is no text provided to rewrite.

Uses of Vianglip SM 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Vianglip SM 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vianglip SM 50mg/500mg Tablet whole; do not crush, chew, or break it. Administer this medicine with a meal.

Common Side effects of Vianglip SM 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Vianglip SM 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Vianglip SM 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Vianglip SM 50mg/500mg Tablet works:

Vianglip SM 50mg/500mg tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vianglip SM 50mg/500mg Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vianglip SM 50mg/500mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vianglip SM 50mg/500mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vianglip SM 50mg/500mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. Vianglip SM 50mg/500mg Tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Vianglip SM 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided unless specifically directed by a physician. Medical consultation is recommended.

What if you forget to take Vianglip SM 50mg/500mg Tablet :

Should you forget to take your Vianglip SM 50mg/500mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vianglip SM 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vianglip SM 50mg/500mg Tablet

Vianglip SM 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Prolonged use of Vianglip SM 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, yearly supplemental vitamin B12 is recommended by some researchers.
Vianglip SM 50mg/500mg Tablets may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Vianglip SM 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Vianglip SM 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Vianglip SM 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from high blood lactic acid levels. This rare side effect is reason for caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Vianglip SM 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18 years old.
Vianglip SM 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Vianglip SM 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Vianglip SM 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Vianglip SM 50mg/500mg (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Vianglip SM 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vianglip SM 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. Vianglip SM is not suitable for individuals under 18.
Vianglip SM 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Vianglip SM 50mg/500mg Tablets are contraindicated in patients with allergies to any component or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Vianglip SM 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Vianglip SM 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is a reason to avoid this medication in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Vianglip SM and seek immediate medical attention.
Prolonged Vianglip SM 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vianglip SM 50mg/500mg Ta...
204